Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study

Dose escalation in lung cancer: have we gone full circle?

(2015) Corinne Faivre-Finn   LANCET ONCOLOGY

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

(2015) Jeffrey D Bradley et al.   LANCET ONCOLOGY

Intensity-Modulated Radiotherapy for Lung Cancer: Current Status and Future Developments

(2014) Clara Chan et al.   Journal of Thoracic Oncology

Concurrent Chemoradiotherapy for Locally Advanced, Unresectable Non-small Cell Lung Cancer: A UK Survey of Current Practice

(2012) J. Helbrow et al.   CLINICAL ONCOLOGY

PO-0961 ISOTOXIC RADIOTHERAPY FOR NON-SMALL CELL LUNG CANCER: IS IMRT THE ANSWER?

(2012) M. Warren et al.   RADIOTHERAPY AND ONCOLOGY

Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer

(2010) David Palma et al.   CURRENT OPINION IN ONCOLOGY

Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer

(2010) Angela van Baardwijk et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

(2010) Anne Aupérin et al.   JOURNAL OF CLINICAL ONCOLOGY

Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study

(2008) D. D. Ruysscher et al.   ANNALS OF ONCOLOGY

Individualized Radical Radiotherapy of Non–Small-Cell Lung Cancer Based on Normal Tissue Dose Constraints: A Feasibility Study

(2008) Angela van Baardwijk et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS